Regulation & Compliance

A landmark FDA approval for Bracco's VUEWAY allows high-quality MRI scans in neonates with half the standard gadolinium dose, easing safety concerns.

With its lead CAR-T therapy, Descartes-08, in late-stage trials, Cartesian Therapeutics is set to update investors on its pioneering work in autoimmune disease.

With a soaring stock, $300M in new funding, and strong clinical data, Monte Rosa is set to showcase its novel disease-fighting drug platform.

A 94% surge in water damage claims reveals a growing crisis, yet a new survey shows over half of Canadians plan no action to protect their homes.

A new partnership uses AI to slash localization costs, bringing a flood of previously unavailable TV shows to European viewers on free streaming channels.

AI legal service provider DocLegal.ai issues a cease-and-desist to a confusingly similar domain, highlighting growing brand protection risks in tech.

At EuroShop 2026, Hanshow unveils AI-powered shelves and smart carts designed to create a 'digital twin' of physical stores, promising a new era of efficiency.

With AI complexity soaring, Gartner's new Market Guide recognizes platforms like TrueFoundry, signaling a shift toward centralized AI governance and control.

The company shed debt and unprofitable revenue in 2025, betting its future on its VLN® cigarette ahead of a potential FDA nicotine crackdown.

NioBay Metals reaffirms its commitments, but the Moose Cree First Nation declares there is "no path forward" for a mine on its sacred ancestral lands.

The credit card issuer settled a California lawsuit alleging excessive and harassing phone calls, part of a wider crackdown on collection practices.

The family-run firm marks two years of platform growth, betting its community revitalization model can thrive in a complex real estate landscape.

Inside the FJA's Founders Luncheon, where a surprise from John Morgan, a new historic award, and family legacies took center stage.

Empire State Realty Trust affirms its Q1 2026 dividend, signaling financial health amidst a shifting NYC market. What does this mean for investors?

The FDA is reviewing a new, more affordable alternative to the costly arthritis drug Orencia, potentially saving patients and the healthcare system billions.

Concentric Energy Advisors hires Erica Menard, a 25-year utility expert, signaling a strategic push to master evolving energy and water regulations.

As insurers face staggering acquisition costs, new platform QuoteNest launches with a promise: deliver quality prospects, not just massive lead lists.

Dr. Joss Reimer, a veteran of Manitoba's COVID-19 response, takes the helm at PHAC, facing a slate of crises from measles to misinformation.

A push to simplify mortgage credit checks could raise rates and reduce access to loans, with a new study revealing the hidden financial risks for consumers.

Triton's new virtual counter aims to modernize police services, but the move online raises critical questions about security, privacy, and public trust.